Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial of neflamapimod in dementia with Lewy bodies (DLB), ...

Dementia with Lewy bodies is the third most common disease that causes dementia. Both risk genes and faulty genes can be involved in dementia with Lewy bodies. Dementia with Lewy bodies (DLB) is ...

These symptoms affect day-to-day life. Dementia is caused by different diseases. Dementia with Lewy bodies is the third most common disease that causes dementia after Alzheimer’s disease and vascular ...

A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

1 Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University College of Physicians and Surgeons, New York, NY, USA 2 Department of Pathology and Cell ... differentiate ...

TEL AVIV, Israel — The Palestinian militant group Hamas has returned the bodies of four Israeli hostages in exchange for Israel releasing hundreds of Palestinian prisoners and detainees.

THE health hazards of asbestos have been recognized for 40 years. Nevertheless, the problems of asbestos pneumoconiosis (asbestosis) and asbestos-related neoplasms have increased alarmingly ...

CAIRO (AP) — Hamas was set to hand over the bodies of four hostages late Wednesday in exchange for Israel’s release of hundreds of Palestinian prisoners, days before the first phase of their ...

CNSA Specifically, “foreshore deposits,” were discovered — a downwards-sloped sand formation brought about by the working of the tides and waves of a body of water. “This stood out to us ...

Hamas handed over the bodies of four Israeli hostages while it waited for hundreds of Palestinian prisoners to be released by Israel in return, in an overnight exchange marking the final swap as ...

The anti-amyloid drug indications are specifically targeted for patients with Alzheimer's disease, not other causes of dementia such as dementia with Lewy bodies, frontotemporal dementia ...